Standout Papers

Myeloid-derived suppressor cells in cancer: therapeutic targets to overcome tumor immune evasion 2024 202655
  1. Myeloid-derived suppressor cells in cancer: therapeutic targets to overcome tumor immune evasion (2024)
    Junli Lu, Yiming Luo et al. Experimental Hematology and Oncology

Immediate Impact

46 standout
Sub-graph 1 of 22

Citing Papers

Molecular mechanisms and therapeutic strategies in overcoming chemotherapy resistance in cancer
2025 Standout
Tailoring traditional Chinese medicine in cancer therapy
2025 Standout
2 intermediate papers

Works of Yiming Luo being referenced

RHO GTPase family in hepatocellular carcinoma
2022
CD4+ T cell-mediated cytotoxicity is associated with MHC class II expression on malignant CD19+ B cells in diffuse large B cell lymphoma
2017

Author Peers

Author Last Decade Papers Cites
Yiming Luo 149 88 81 34 319
Chengxin Luo 118 95 87 23 339
Mumtaz Anwar 181 52 37 29 343
Jing Ling 109 34 98 47 270
Fanjun Cheng 165 97 43 26 327
Mi Zhou 206 54 52 26 342
Xingkui Xue 172 85 72 19 320
Yingxin Sun 187 45 33 33 312
Xue Jun Zhang 179 90 101 22 368
Xingxing Chai 204 67 62 24 346
Cong Fu 205 45 46 16 328

All Works

Loading papers...

Rankless by CCL
2026